Hearty Thomas M, Schenkman Margaret L, Kohrt Wendy M, Cress M Elaine
School of Medicine, Physical Therapy Program, University of Colorado Health Science Center, Denver, Colorado, USA.
J Neurol Phys Ther. 2007 Jun;31(2):64-70. doi: 10.1097/NPT.0b013e3180676afa.
Functional measures are needed that are applicable to middle-aged adults with neurological disorders who are on the threshold of disability. One potential measure is the Continuous Scale Physical Functional Performance Test (CS-PFP), which has been normalized and validated to older adults but performance is unknown for adults younger than the age of 65 years with and without neurological disorders. The purposes of this investigation were (1) to compare scores on the CS-PFP of nondisabled adults in three age groups from 35 to 64 years with two groups of individuals older than the age of 65; (2) to determine whether there is a ceiling effect for nondisabled middle-aged adults; and (3) to determine whether performance of individuals in early stages of Parkinson's disease (PD) age 45 to 64 years differ significantly from performance of similarly aged nondisabled adults.
Data were obtained from three samples: (1) 37 adults with PD (45-54 and 55-64 years; 57% female), (2) 70 nondisabled adults (35-44, 45-54, and 55-64 years; 69% female); (3) 72 nondisabled older adults (65-74 and 75-85 years; 79% female). The CS-PFP was administered in a single test session for each subject. Analysis of variance was performed for group differences with adjustment of sex as a covariate followed by a Student-Newman-Keuls post hoc analysis.
For nondisabled individuals, the CS-PFP total and domain scores were significantly lower in the oldest group (75-85 years) compared to all other age groups and significantly higher in the younger two groups (35-44 and 45-54 years) compared to the older groups. There was no ceiling effect for any domain score or total score for the adults younger than 65 years. For individuals with PD, both age groups had significantly lower scores on the CS-PFP than did the nondisabled counterparts.
Results from the nondisabled middle-aged individuals provide comparison data to be used clinically or in investigations of middle-aged adults with neurological dysfunction. Comparison of middle-aged individuals with PD to middle-aged nondisabled adults illustrates the true extent of functional difficulty experienced by individuals with PD and demonstrates the importance of using age appropriate comparison data. The CS-PFP is particularly applicable to middle-aged adults with compromised functional performance for their age but is too high to be effectively quantified with other assessment measures.
需要适用于处于残疾临界状态的患有神经系统疾病的中年成年人的功能测量方法。一种潜在的测量方法是连续量表身体功能表现测试(CS-PFP),该测试已针对老年人进行了标准化和验证,但对于65岁以下患有和未患有神经系统疾病的成年人的表现尚不清楚。本研究的目的是:(1)比较35至64岁三个年龄组的非残疾成年人与两组65岁以上个体在CS-PFP上的得分;(2)确定非残疾中年成年人是否存在天花板效应;(3)确定45至64岁帕金森病(PD)早期患者的表现与同龄非残疾成年人的表现是否有显著差异。
数据来自三个样本:(1)37名PD患者(45 - 54岁和55 - 64岁;57%为女性),(2)70名非残疾成年人(35 - 44岁、45 - 54岁和55 - 64岁;69%为女性);(3)72名非残疾老年人(65 - 74岁和75 - 85岁;79%为女性)。对每个受试者在单次测试中进行CS-PFP测试。进行方差分析以比较组间差异,并将性别作为协变量进行调整,随后进行Student-Newman-Keuls事后分析。
对于非残疾个体,与所有其他年龄组相比,最年长组(75 - 85岁)的CS-PFP总分和领域得分显著更低,与年长组相比,较年轻的两组(35 - 44岁和45 - 54岁)的得分显著更高。65岁以下成年人的任何领域得分或总分均不存在天花板效应。对于PD患者,两个年龄组在CS-PFP上的得分均显著低于非残疾对照组。
非残疾中年个体的结果提供了可用于临床或用于对患有神经功能障碍的中年成年人进行研究的比较数据。将中年PD患者与中年非残疾成年人进行比较,说明了PD患者所经历的功能困难的真实程度,并证明了使用年龄合适的比较数据的重要性。CS-PFP特别适用于功能表现与其年龄不相称的中年成年人,但对于他们来说过高,无法通过其他评估方法有效量化。